Bionano Genomics closes $10M public offering of 5M shares and warrants

Bionano Genomics, Inc.

Gross proceeds of $10M from sale of 5M shares and Series E/F warrants to purchase up to 10M shares.
Net proceeds approximately $9.0M after placement agent fees and offering expenses.
Warrants exercisable at $2.00 per share; Series E expire in 5 years, Series F in 18 months.
Proceeds to be used for working capital and general corporate purposes.
Offering closed on September 17, 2025; H.C. Wainwright acted as exclusive placement agent.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.